DIANEAL PD-2 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER Drug Patent Profile
✉ Email this page to a colleague
When do Dianeal Pd-2 W/ Dextrose 2.5% In Plastic Container patents expire, and when can generic versions of Dianeal Pd-2 W/ Dextrose 2.5% In Plastic Container launch?
Dianeal Pd-2 W/ Dextrose 2.5% In Plastic Container is a drug marketed by Baxter Hlthcare and is included in two NDAs.
The generic ingredient in DIANEAL PD-2 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER is calcium chloride; dextrose; magnesium chloride; sodium chloride; sodium lactate. There are two hundred and eighty-two drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the calcium chloride; dextrose; magnesium chloride; sodium chloride; sodium lactate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DIANEAL PD-2 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER?
- What are the global sales for DIANEAL PD-2 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER?
- What is Average Wholesale Price for DIANEAL PD-2 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER?
Summary for DIANEAL PD-2 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Finished Product Suppliers / Packagers: | 1 |
| Clinical Trials: | 6 |
| DailyMed Link: | DIANEAL PD-2 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER at DailyMed |
Recent Clinical Trials for DIANEAL PD-2 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Iperboreal Pharma Srl | Phase 3 |
| Baxter Healthcare Corporation | Phase 3 |
| Baxter Healthcare Corporation | Phase 4 |
See all DIANEAL PD-2 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER clinical trials
Pharmacology for DIANEAL PD-2 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER
US Patents and Regulatory Information for DIANEAL PD-2 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baxter Hlthcare | DIANEAL PD-2 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER | calcium chloride; dextrose; magnesium chloride; sodium chloride; sodium lactate | SOLUTION;INTRAPERITONEAL | 017512-005 | Approved Prior to Jan 1, 1982 | AT | RX | Yes | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| Baxter Hlthcare | DIANEAL PD-2 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER | calcium chloride; dextrose; magnesium chloride; sodium chloride; sodium lactate | SOLUTION;INTRAPERITONEAL | 020163-002 | Dec 4, 1992 | AT | RX | Yes | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
